PillTracker

PillTracker Overview

PillTracker is an adherence system that helps patients and doctors collaboratively manage medication consumption. Leveraging a patented conductive layer, advanced Qualcomm chipset, and a familiar Android-based user interface, PillTracker streamlines adherence throughout the lifecycle of the medication for the patient and doctor alike. PillTracker approaches medication adherence from both directions, reminding the patient about their prescribed dose, while tracking their medication use in near-real time on behalf of the healthcare provider. All of this is made possible by smart blister packaging paired with a user-friendly medication dispenser. PillTracker enables precise and efficient clinical trials by tracking medication use in near-real time, accepting patient feedback, and offering direct engagement between study staff and participants. PillTracker extends electronic clinical trial management systems into the hands of the patient. Additionally, study staff can update prescribed dosing for patients, send them notifications, and accept formal case report forms through the device.

Cumulative Funding Raised Over Time ($)

Latest News

Dec 4, 2019 · www.prnewswire.com

growth-positive

PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority

Israeli medication adherence start-up PillTracker has joined the PMatX Innovation Lab to accelerate the development of its medication adherence solution. The lab, operated by M Ventures and supported by Merck, FLEX, and the Israel Innovation Authority, serves as an innovation lab for Israeli start-ups developing next-generation electronics innovations. PillTrackers technology, which uses cellular-enabled smart packaging and cloud-connectivity, initially targets medication adherence in clinical trials and will expand to support patient compliance for post-market specialty pharmaceuticals. The company will receive funding and strategic mentorship support from Merck, Flex, and the Israel Innovation Authority through the PMatX program. PillTracker aims to launch its next-generation clinical trial medication compliance platform in Q2 2020.

Partners

Jul 5, 2017 · www.israel21c.org

growth-positive

BIRD to invest $7 million in 8 new Israel-US projects

The Israel-US Binational Industrial Research and Development (BIRD) Foundation has approved $7 million in funding for eight new projects between American and Israeli companies. The projects cover various areas such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The funding from BIRD will be supplemented by private sector funding, bringing the total value of the projects to approximately $18.5 million. The BIRD Foundation has been instrumental in promoting collaboration between US and Israeli companies, with a total investment of about $340 million in joint projects. This funding will further support the growth and development of valuable collaborations between companies in both countries.

Investment

Jun 29, 2017 · www.jpost.com

growth-positive

https://www.jpost.com/Israel-News/Israel-US-foundation-commits-7m-to-eight-hi-tech-R-and-D-partnerships-498221

The Israel-US Binational Industrial Research and Development Foundation (BIRD) will invest $7 million in eight new Israeli-American projects across various hi-tech disciplines. The projects will receive conditional grants of up to $1 million each, focusing on topics such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The companies involved will also have access to private sector funding, bringing the total value of the projects to $18.5 million. The funding was approved on June 14 at a BIRD board of governors meeting in Washington. BIRD, established in 1977, has invested over $340 million in joint projects, generating more than $10 billion in direct and indirect revenue.

Investment

Jun 28, 2017 · www.prnewswire.com

growth-positive

BIRD - Israel-U.S. Binational Industrial R&D Foundation to Invest $7 Million in Eight New Projects

The BIRD Foundation, a collaboration between U.S. and Israeli companies, has approved $7 million in funding for eight new projects. These projects will also access private sector funding, bringing the total value to approximately $18.5 million. The BIRD Foundation promotes joint product development and provides grants of up to $1 million for approved projects. The projects approved cover a range of technological fields, including 3D culture platforms, colon cancer screening systems, and personalized nutrition recommendations. The BIRD Foundation has approved over 940 projects in its 40-year history, with a total investment of about $340 million. The deadline for the next project cycle is September 7, 2017.

PartnersInvestment

Funding

Team Members

1

Employees: 1-10

Web & Social Links

Locations

HaPelech St 7, Tel Aviv-Yafo, Israel

New York, NY, USA

Photos & Videos

3 item(s)

PillTracker Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info